Insight into neurocognitive dysfunction in schizophrenia

Schizophrenia Bulletin
Alice Medalia, Julie Thysen

Abstract

Insight into psychotic symptoms is typically poor in schizophrenia; however, it is not known whether insight into neurocognitive impairment is similarly impaired. Most people with schizophrenia experience cognitive dysfunction, and the deficits in attention, memory, and critical thinking have been associated with poor functional outcome. As new treatments are developed for the cognitive impairments, it will be important to know whether patients will be receptive to yet another therapy. Insight is an important factor in treatment compliance and treatment outcome; however, it is not known if patients have insight into their cognitive dysfunction. In order to assess insight into neuro cognitive dysfunction, 75 subjects were administered the Measure of Insight into Cognition-Clinician Rated, a newly created measure based on the Scale to Access the Unawareness of Mental Disorder, that assesses insight into cognitive impairment. Subjects were also administered the Brief Assessment of Cognition in Schizophrenia and Independent Living Scale-Problem Solving to objectively assess neuropsychological status and problem-solving skills needed for independent living. Results demonstrated that virtually all subjects had cognitive impairment, y...Continue Reading

References

Jan 1, 1991·Schizophrenia Bulletin·X F AmadorJ M Gorman
Jan 1, 1989·The Journal of Nervous and Mental Disease·J P McEvoyL Roth
Mar 1, 1989·Journal of Clinical and Experimental Neuropsychology·S M McGlynn, D L Schacter
Jan 1, 1994·Acta Psychiatrica Scandinavica·M BirchwoodM Slade
Jun 1, 1993·The American Journal of Psychiatry·X F AmadorJ M Gorman
Mar 1, 1996·The American Journal of Psychiatry·M F Green
Jul 8, 1998·The Journal of Nervous and Mental Disease·R J van den Bosch, R P Rombouts
Apr 28, 1999·Journal of the International Neuropsychological Society : JINS·J A GladsjoD V Jeste
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·M J CuestaA Zarzuela
Feb 6, 2004·Journal of Psychiatric Research·Robert C Schwartz, Shannon D Smith
Sep 4, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Nadine Revheim, Alice Medalia
Oct 12, 2004·Schizophrenia Research·Alice Medalia, Rosa W Lim
Mar 23, 2005·Biological Psychiatry·Richard S E KeefeMargaret P Poe
May 12, 2005·Schizophrenia Research·Kenneth L SubotnikJim Mintz
Jun 15, 2005·Acta Psychiatrica Scandinavica·M A CookeV Kumari
Sep 17, 2005·Schizophrenia Bulletin·Mark A Geyer, Robert Heinssen
Oct 11, 2005·Journal of the International Neuropsychological Society : JINS·D A CaroneB Weinstock-Guttman
Dec 6, 2005·Neuropsychology Review·Jasmeet K Pannu, Alfred W Kaszniak
Jan 31, 2006·Schizophrenia Research·Nadine RevheimDaniel C Javitt
Feb 8, 2006·The Journal of Nervous and Mental Disease·Julio SanjuánManuel Bousoño
Mar 28, 2006·Schizophrenia Research·Tara A NiendamTyrone D Cannon
Dec 1, 2004·Psychological Science in the Public Interest : a Journal of the American Psychological Society·David DunningJerry M Suls

❮ Previous
Next ❯

Citations

Jun 8, 2010·Current Psychiatry Reports·Marjorie Baier
Sep 21, 2010·Schizophrenia Bulletin·J GilleenA S David
Sep 1, 2011·Schizophrenia Bulletin·Elizabeth W TwamleyLea Vella
Apr 12, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Anthony S DavidJames Gilleen
Mar 27, 2012·Psychiatry and Clinical Neurosciences·Mounir OuzirOmar Battas
Mar 2, 2011·The Australian and New Zealand Journal of Psychiatry·Simon ZhornitskyEmmanuel Stip
Sep 4, 2012·The Journal of Clinical Psychiatry·Elizabeth W TwamleyDilip V Jeste
Jul 9, 2013·Medicina clínica·Oriol Turró-GarrigaJosep Garre-Olmo
Jan 27, 2016·Schizophrenia Research·Cynthia Z BurtonElizabeth W Twamley
Mar 13, 2012·Psychiatry Research·Sara PolettiRoberto Cavallaro
Feb 24, 2009·Schizophrenia Research·Juan ZhangYan Shen
May 5, 2012·International Journal of Geriatric Psychiatry·Oriol Turró-GarrigaSecundino López-Pousa
Dec 6, 2012·International Journal of Mental Health Nursing·Robert KingEmma White
Mar 1, 2011·Early Intervention in Psychiatry·Rosa Ayesa-ArriolaBenedicto Crespo-Facorro
Jul 25, 2014·International Journal of Geriatric Psychiatry·Philip GerretsenAriel Graff-Guerrero
Oct 11, 2015·Psychiatry Research·Chien-Yeh ChiuMau-Sun Hua
Sep 29, 2011·Schizophrenia Research·B González-SuárezP J McKenna
Jul 6, 2013·Schizophrenia Research·Daniel V HoltStefan Kaiser
Dec 24, 2014·Schizophrenia Research·Cynthia Z Burton, Elizabeth W Twamley
Apr 16, 2014·Schizophrenia Research·Stéphane RaffardYannick Stephan
Oct 1, 2011·American Journal of Psychiatric Rehabilitation·Cynthia Z BurtonElizabeth W Twamley
Dec 19, 2013·Journal of Clinical and Experimental Neuropsychology·James GilleenAnthony S David
Apr 23, 2014·Cognitive Neuropsychiatry·Ryan P BalzanCherrie Galletly
Nov 2, 2014·Cognitive Neuropsychiatry·Antoinette ProuteauHélène Verdoux
May 5, 2016·Journal of Clinical and Experimental Neuropsychology·Ivan J TorresLakshmi N Yatham
Aug 16, 2016·Schizophrenia Research and Treatment·Audrey BenoitMartin Lepage
Sep 7, 2016·Journal of Psychiatric Research·Marta de Castro-CatalaAraceli Rosa
Dec 20, 2016·European Psychiatry : the Journal of the Association of European Psychiatrists·J Elowe, P Conus
Apr 5, 2014·Journal of Geriatric Psychiatry and Neurology·Oriol Turró-GarrigaJosep Lluís Conde-Sala
Mar 28, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·Sophie BayardStéphane Raffard
Dec 20, 2017·The Journal of Nervous and Mental Disease·Tim BastiaensMarc De Hert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.